Janet Woodcock and the Food and Drug Administration (FDA) Make Pronouncement on Zantac and Ranitidine Products

The United States Food and Drug Administration (FDA), led by Janet Woodcock, recently recommended the removal of any drug on the market that contain ranitidine or ranitidine products, circa April 1 2020. Many heartburn medications (also called H2 blockers) like Zantac have ranitidine in them.

In fact, ranitidine is the medical term for Zantac. Zantac is an over the counter drug meant to treat GERD, heartburn, acid reflux, and other side effects. These ranitidine medications and all ranitidine products or ranitidine drugs (including otc ranitidine) have NDMA in them and ranitidine products increases the chances of cancer if the NDMA is at unacceptable levels per FDA warning.